Monthly Archives: June 2019

One of the risk factors for rheumatoid arthritis has been linked to periodontal disease. A study from Japan was presented at the recent European Rheumatology Conference (EULAR). It found that people who had rheumatoid arthritis along with periodontal disease had … Continue reading →

At the European rheumatology conference, known as EULAR, there were several sessions held simultaneously over the four day meeting. There were over 16,000 people in attendance. One of the sessions focused on safety. United States physician Dr. Kevin Winthrop outlined … Continue reading →

Our pharmacist Carolyn Whiskin is in Madrid this week attending the largest Rheumatology conference in the world (EULAR).  She will be reporting back on the newest findings reported at this meeting over the next several weeks. There will be over … Continue reading →

Skyrizi (risankizumab) is a new biologic for treating psoriasis. The first dose in Canada was injected at Charlton Health.  This treatment is given by injection as 2 prefilled syringes starting at week 0, week 4 and then every 12 weeks.  … Continue reading →